Ultrasonography measurement of intrabdominal visceral fat in obese men. Association with alterations in serum lipids and insulinemia;Medición ultrasonográfica de grasa visceral intraabdominal en hombres obesos. Asociación con alteración de lípidos séricos e insulinemia

Archivos Latinoamericanos de Nutricion

Volumn 60, Issue 2, 2010, Pages 160-167

  Navarro, Edgar ^a,b,c   Mijac, Volga ^a,b,c   Flórez, Hermes ^a,b,c   Ryder, Elena ^a,b,c  

^a Clínica Industrial Anaco   (Venezuela)

^b UNIVERSIDAD DEL ZULIA   (Venezuela)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

Insulinemia; Serum lipids; Ultrasound; Visceral fat

Indexed keywords

INSULIN; LIPID;

ADULT; ARTICLE; BLOOD; ECHOGRAPHY; HUMAN; INTRAABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY; VENEZUELA;

ADULT; HUMANS; INSULIN; INTRA-ABDOMINAL FAT; LIPIDS; MALE; MIDDLE AGED; OBESITY; VENEZUELA; YOUNG ADULT;

EID: 79958292742     PISSN: 00040622     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Garg A. Regional adiposity and insulin resistance. J Clin Endocrinol Metab; 2004 89(9):4206-4210. (Pubitemid 39244411)
2. Després JP. Abdominal obesity: the most prevalent cause of metabolic syndrome and related cardiometabolic risk. Eur Heart J 2006 Supplements (Suppl B) 2006: B4-B12.
3. Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162(16): 1867-1872.
4. Kissebah AH. Central obesity: measurement and metabolic effects. Diabet Rev 1997; 5:8-20. (Pubitemid 27198911)
5. Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of diabetes epidemic. Nature 2001; 414:782-787. (Pubitemid 34000780)
6. Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res 2004; 59:207-223. (Pubitemid 41327152)
7. Ford E, Giles W. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287:356-359. (Pubitemid 34251969)
8. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS et al. Diabetes Metab 2002; 28: 364-376.
9. Franco J, Ferrer J, Jurisa A, Vargas A. Obesidad como factor de riesgo para hipertensión arterial. Salus militiae 1998; 23 (1): 5-13.
10. García-Araujo M, Semprún-Fereira M, Sulbaran TA, Silva E, Calmon G, Campos G. Factores metabólicos y nutricionales como factores de riesgo para enfermedades cardiovasculares in una población adulta de la ciudad de Maracaibo, estado Zulia, Venezuela. Invest Clin 2001; 42: 23-42.
11. Campos G, Ryder E, Diez-Ewald M, Rivero F, Fernández V, Raleigh X et al. Prevalence of obesity and hiperinsulinemia: its association with serum lipid and lipoprotein in healthy individuals from Maracaibo-Venezuela. Invest Clin 2003; 44:5-19. (Pubitemid 36433896)
12. Flórez H, Silva E, Fernández V, Ryder E, Sulbaran T, Campos G et al. Prevalence and risk factors associated with the metabolic syndrome and dyslipidemia in White, Black, Amerindians and Mixed Hispanics in Zulia state, Venezuela. Diab Res Clin Pract 2005; 69: 63-77. (Pubitemid 40813413)
13. Nuñez R, Peña A, Pacheco B, Sánchez M, Rivera M. Obesidad en pacientes adultos del Municipio Sucre del Estado Miranda. AVFT 2006; 25:64-66.
14. Ruiz-Fernández N, Espinoza M, Barrios E, Reigosa A. Factores cardiometabólicos en una comunidad de Valencia, Venezuela. Rev salud publica 2009; 11:383-394.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285:2486-2496.
16. Mathews D, Hosker J, Rudenski A, Neylor B, Tracher D, Turner R. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419. (Pubitemid 15018832)
17. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven G. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 2000; 23:171-175. (Pubitemid 30071019)
18. Armellini F, Zamboni M, Rigo L, Todesco T, Bergamo-Andreis IA, Procacci C et al. The contribution of sonography to the measurement of intrabdominal fat. J Clin Ultrasound 1990; 18:563-567. (Pubitemid 20250729)
19. Montero JC. Epidemiología de la obesidad en siete países de América Latina. Form Contin Nutr Obes 2002; 5(5):000-000
20. Filozof C, Gonzalez C, Sereday M, Mazza C, Bragunsky J. Obesity prevalence and trends in Latin-American countries. Obes Rev 2001; 2:99-106. (Pubitemid 33755919)
21. Haffner S, Taegtmeyer H. Epidemic Obesity and Metabolic Syndrome. Circulation 2003; 108:1541-1545.
22. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich- Horvat P, Liu CY et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007; 116: 39-48. (Pubitemid 47016245)
23. Tornaghi G, Raiteri R, Pozzato C, Rispoli A, Bramani M, Cipolat M et al. Anthropometric or ultrasonic measurements in assessment of visceral fat? A comparative study. Int J Obes Relat Metab Disord 1994; 18:771-775 (Pubitemid 24334523)
24. Armellini F, Zamboni M, Rigo L, Bergamo-Andreis IA, Robbi R, De Marchi M, et al. Sonography detection of small intraabdominal fat variations. Int J Obesity 1991; 15:847-852
25. Stolk R, Meijer R, Mali W, Grobbee D, van der Graf Y. Ultrasound measurement of intrabdominal fat estimate the metabolic syndrome better than do measurements or waist circumference. Am J Clin Nutr 2003; 77:857-860.
26. De Lucia Rolfe E, Sleigh A, Finucane FM, Brage S, Stolk RP, Cooper C et al. Ultrasound measurements of visceral and subcutaneous abdominal thickness to predict abdominal adiposity among older men and women. Obesity (Silver Spring) 2010; 18:625-631.
27. Kim SK, Kim HJ, Hur KY, Choi SH, Ahn CW, Lim SK. Visceral fat thickness measured by ultrasonography can estimate not only visceral obesity but also risks of cardiovascular and metabolic diseases. Am J Clin Nutr 2004; 79:593-599.
28. Leite CC, Wajchenberg BL, Radominsky R, Matsuda D, Cerri GG, Halpern A. Intra-abdominal thickness by ultrasonography to predict risk factors for cardiovascular disease and its correlation with anthropometric measurements. Metabolism 2002; 51:1034-1040.
29. Ribeiro-Filho FF, Faria AN, Azjen S, Zanella MT, Ferreira SR. Methods of estimation of visceral fat: advantages of ultrsonography. Obes Res 2003; 11:1488-1494. (Pubitemid 41127333)
30. Chiba Y, Saitoh S, Takagi S, Ohnishi H, Katoh N. Ohata J et al. Relationship between visceral fat and cardiovascular disease risk factors: the Tanno and Sobetsu Study. Hypertens Res 2007; 30:229-236. (Pubitemid 46605447)